ISDS Case Map
corporate interests
One of WikiLeaks' greatest achievements has been to expose the exorbitant amount of influence that multinational corporations have over Washington's diplomacy.
Prime Minister Julia Gillard says she won't be intimidated by big tobacco after Philip Morris launched legal action to try to force the government to back down on introducing plain packaging for cigarettes.
The new head of the U.S. business community in South Korea said Wednesday that he is "optimistic" about the early ratification of a bilateral free trade deal and is doing his best to achieve it.
The TPP chapter may be best seen as a significant step toward the pharmaceutical industry’s ultimate goal, which is a binding international agreement on drug pricing that would restrain the ability of governments to use collective purchasing power to demand prices below “market” levels.
The office of Ecuador's Attorney General will represent Ecuador in Washington at a June 30 hearing in the arbitration case filed against the Andean country by US oil company Occidental Petroleum Corp.
One of the world’s biggest tobacco companies is launching a claim against Uruguay for considering the country’s legislation commercially damaging to the company. Philip Morris corporation has filed a claim at the International Centre for Settlement of Investment Disputes (ICSID), a World Bank branch.
Spain’s tuna canning industry is feeling under attack by Papua New Guinea’s privileged access to the European Union market. Spain is consequently engaging in a smear campaign against the tariff-free market access of PNG and the Parties to the Nauru Agreement, a fisheries industry consultative meeting was told this week.
"Commercially meaningful bilateral agreements must be passed now or the United States will be left behind," warns Greg Page, the head of Cargill.
Cargill today hosted an employee forum and a business roundtable discussion on the US–South Korea Free Trade Agreement (KORUS FTA), which is currently pending Presidential notification to and approval from U.S. Congress.
Canadians spend a lot of money (public and private) on health care and much of that is spent on drugs — some $23.4 billion in 2008. Provincial insurance plans are desperately trying to cope, looking to initiatives like the recently passed Ontario law that caps prices of generic drugs at 25 per cent of the brand name equivalent.
